雌激素受体影响泌乳素瘤发生的作用途径
被引量:2
Pathways of estrogen receptors participate in prolactinomas genesis
摘要
腺垂体通过分泌激素和细胞可逆性改变来对内外环境中的信息做出反应,但可逆的细胞功能性改变可能发展为增生、分化,甚至是腺瘤。垂体腺瘤约占颅内新生物的10%~25%,
出处
《局解手术学杂志》
2014年第1期84-86,共3页
Journal of Regional Anatomy and Operative Surgery
基金
国家自然科学基金(81071043)
参考文献12
-
1Dworakowska D, Grossman AB. The pathophysiology of pituitary adeno- mas[ J]. Best Pratt Res Clin Endocrinol Metab, 2009,23 ( 5 ) : 525 - 541.
-
2Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes [ J ]. Mol Endocrino1,2005,19 (4) : 833 - 842.
-
3Burdman JA,Pauni M,Heredia Sereno GM, et al. Estrogen receptors in human pituitary tumors[ J ]. Horm Metab Res,2008,40 (8) :524 -527.
-
4Couse JF, Yates MM, Walker VR, et al. Characterization of the hypotha- lamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice re- veals hypergonadism and endocrine sex reversal in females lacking ERol but not ERβ [ J ]. Mol Endocrino1,2003,17 (6) :1039 - 1053.
-
5Ben Jonathan N,Chen S,Dunckley JA,et al. Estrogen receptor-α medi- ates the epidermal growth factor-stimulated prolactin expression and re- lease in lactotrophs [ J ]. Endocrinology, 2009,150 ( 2 ) :795 - 802.
-
6Carroll JS, Liu XS, Brodsky AS, et al. Chromosome-wide mapping of es- trogen receptor binding reveals long-range regulation requiring the fork- head protein FoxA1 [ J ]. Cell,2005,122 ( 1 ) :33 - 43.
-
7Adamson AD, Friedrichsen S, Semprini S, et al. Human prolactin gene promoter regulation by estrogen:convergence with tmnor necrosis factor- α signaling [ J ]. Endocrinology ,2008,149 ( 2 ) :687 - 694.
-
8Lv H, Li C, Gui S, et al. Effects of estrogen receptor antagonist on bio- logical behavior and expression of growth factors in the prolactinoma MMQ cell line[J].J Neurooncol,2011,102(2) :237 -245.
-
9Hou Y,Yang SP, Voogt JL. Changes in estrogen receptor-α expression in hypothalamic dopaminergic neurons during proestrous prolactin surge [J]. Endocrine,2003,20( 1 -2) :131 - 138.
-
10Wu ZB, Li CZ, Zong XY, et al. Correlation of alternative splicing of the D2 dopamine receptor mRNA and estrogen receptor mRNA in the pro- lactinomas and gonadotrope tumors [ J ]. J Neurooncol, 2009,94 ( 1 ) :135 - 139.
同被引文献28
-
1Colao A. Pituitary tumours : the prolactinoma [ J ]. Best Pract ResClin Endocrinol Metab,2009,23(5) :575-596.
-
2Kasantikul V,Shuan逆hoti S. Pituitary adenomas: immunohisto-chemical: study of 90 cases [ J ]. J Med Assoc Thai, 1990,73?9) ;514-521.
-
3Berezin M, Shimon I,Hadani M. Prolactinoma in 53 men:clinical characteristics and modes of treatment ( maleprolactinoma) [ J] . J Endocrinol Invest ,1995 ,18(6) :436-441.
-
4Colao A,Samo AD,Cappabianca P,et al. Gender differences inthe prevalence, clinical features and response to cabergoline inhyperprolactinemia [ J ] . Eur J Endocrinol, 2003,148 ( 3 );325-331.
-
5Delgrange E, Trouillas J, Maiter D, et ai. Sex-related differencein the growth of prolactinomas : a clinical and proliferation markerstudy[ J]. J Clin Endocrinol Metab, 1997 ,82(7) :2102-2107.
-
6Ippersiel W, Misson N, Donckier JE. Dramatic shrinkage of agiant prolactinoma in a male patient under medical management[J]. Acta Clin Belg,2012,67(2) ;140-141.
-
7Lv H, Li C, Gui S,et al. Effects of estrogen receptor antagoniston biological behavior and expression of growth factors in theprolactinoma MMQ cell line[ J]. J Neurooncol,2011,102 (2):237-245.
-
8Lv H, Li C, Gui S, et al. Expression of estrogen receptor alphaand growth factors in human prolactinoma and its correlation withclinical features and gender [ J ]. J Endocrinol Invest,2012,35(2):174-180.
-
9Oh MC, Aghi MK, Dopamine agonist-resistant prolactinomas[J]. J Neurosurg,2011,114(5) : 1369-1379.
-
10Nishioka H,Haraoka J,Akada K. Growth potential ofprolactinomas in men: is it really different from women? [ J].Surg Neurol,2003,59(5) :386-391.
引证文献2
-
1刘阳,时璇,王任直.不同性别垂体催乳素腺瘤患者临床差异与雌激素受体表达的关系[J].中华神经外科杂志,2015,31(8):779-783.
-
2任志文,谢岩,赵冬,刘祺,王洋,许健,王业忠.DAT和D_2R在垂体腺瘤组织中的表达及其意义[J].中国现代医学杂志,2017,27(23):38-42.
-
1郭丽.泌乳素瘤的诊断与治疗[J].世界最新医学信息文摘,2012,12(6):91-92. 被引量:1
-
2周薇,姚孝礼.甲状腺功能减退症合并泌乳素瘤1例报告[J].陕西医学杂志,2002,31(2):189-189.
-
3崔家幸,党秋菊,王艳.无泌乳素瘤的高泌乳素血症30例临床分析[J].中国临床实用医学,2009,3(9):115-115.
-
4焦敏侠,荣艳玲.泌乳素瘤50例临床分析[J].中国煤炭工业医学杂志,2009,12(5):790-791. 被引量:1
-
5王涤非.泌乳素瘤及巨人症和肢端肥大症的诊治[J].中国实用乡村医生杂志,2015,0(9):23-23.
-
6梁敏.孕激素在绝经后骨质疏松中的作用[J].国外医学(内分泌学分册),2003,23(2):136-138. 被引量:9
-
7杨中坚.颅内新生物的诊治要点[J].人民军医,1992,35(12):18-20.
-
8龚燕,顾学章,严峻海.阻塞性睡眠呼吸暂停低通气综合征与慢性阻塞性肺疾病的相关性分析[J].上海医学,2004,27(12):930-930.
-
9季立津,鹿斌,史虹莉.泌乳素瘤发病机制研究进展[J].医学综述,2016,22(1):55-59. 被引量:6
-
10周明,马纪林,陶筱娟.重复肾活检观察中西医结合治疗IgA肾病的疗效[J].浙江中西医结合杂志,2006,16(10):619-620. 被引量:2